Last updated on November 2018

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acne | Acne Vulgaris
  • Age: Between 9 - 100 Years
  • Gender: Male or Female

Eligible male and female participants will be 9 years of age or older, have moderate to severe non-nodular, inflammatory or non-inflammatory acne, and have no other dermatological condition of the face.  Female subjects cannot plan to be pregnant or breast feeding during the study. Subjects must be available for the 6 office visits during the 12 week period and be willing to comply with all study instructions. Several other restrictions and criteria may apply that the study doctor will review with you to determine if you qualify to enter the study.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.